Top View
- Ibogaine: Treatment Outcomes and Observations Two Ibogaine Treatment Providers ([email protected])
- The Efficacy of Ibogaine Use in Opioid Use Disorder Compared to Buprenorphine
- United States Patent (19) 11 Patent Number: 5,925,634 Olney (45) Date of Patent: *Jul
- House Bill No. 2038
- Changes in Gene Expression and Signal Transduction Following Ibogaine Treatment
- “Herbal Seizures” – Atypical Symptoms After Ibogaine Intoxication: a Case
- Pharmacology of Ibogaine and Ibogaine-Related Alkaloids
- Pharmacokinetics, Metabolism, and Pharmaceutics of Drugs of Abuse
- Herbal Remedy
- Psychedelics, Trauma & Addiction
- Drug Fact Sheet
- Findings and Recommendations of the Task Force to Prevent Deaths from Unintentional Drug Overdoses in North Carolina, 2003
- Hallucinogens and Dissociative Drugs
- Morphing of Ibogaine: a Successful Attempt Into the Search for Sigma-2 Receptor Ligands
- List of Scheduling Actions, Controlled Substances And
- Manual for Ibogaine Therapy
- Altered States of Consciousness Drug‐Induced States David E
- Ketamine: Dreams and Realities
- Why Vermonters Should Include Ibogaine in Its Opioid Addiction Treatment Strategy
- Memantine Increases NMDA Receptor Level in the Prefrontal Cortex but Fails to Reverse Apomorphine-Induced Conditioned Place Preference in Rats
- The Use of Ibogaine in the Treatment of Addictions
- 2021-03-29 Psychedelics Against Drug Addiction
- Life After Ibogaine
- Noribogaine, but Not 18-MC, Exhibits Similar Actions As Ibogaine on GDNF Expression and Ethanol Self-Administration
- LSD Lysergic Acid Diethylamide
- NIH Public Access Author Manuscript Addict Biol
- Receptor Binding Profiles and Behavioral Pharmacology of Ring
- Ketamine Psychotherapy for Heroin Addiction: Immediate Effects and Two-Year Follow-Up
- Drugs of Abuse, a DEA Resource Guide (2020 Edition)
- Ibogaine Scientific Literature Overview
- New Compound Related to Psychedelic Ibogaine Could Treat Addiction, Depression 9 December 2020
- Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile
- Memantine Increases NMDA Receptor Level In
- Glial Cell Line-Derived Neurotrophic Factor Mediates the Desirable Actions of the Anti-Addiction Drug Ibogaine Against Alcohol Consumption
- Drug Scheduling
- 1999 Survey of Forensic Reference Materials
- Senate Bill No.1017 (2021)
- The Agency of Ibogaine: Emic Understandings
- Drugs of Abuse (2017 Edition)
- Ex Vivo Effects of Ibogaine on the Activity of Antioxidative Enzymes in Human Erythrocytes
- An Experimental Study to Evaluate the Effect of Memantine in Animal Models Of